Health Alert:

See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.

In this interview, Amit Bar-Or, MD, FRCPC, discusses the evolution of new therapies for multiple sclerosis and the ways in which these therapies are a consequence of a greater understanding of the pathophysiology of the disease. Dr. Bar-Or is Chief of the Multiple Sclerosis Division and at Penn Medicine and the Perelman School of Medicine, and a renowned researcher in the field of neuroinflammation and neurotherapeutics.
Share This Page: